by
Lauren Dubinsky, Senior Reporter | February 02, 2015
A new MarketsandMarkets report predicts the global pre-clinical imaging market is "expected to reach" $797 million by 2019, at a CAGR of 6.0 percent from 2014 to 2019.
The report broke down the global pre-clinical imaging market into seven segments: optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems.
Key factors impacting the market included technological advancements in molecular imaging, rising adoption of multi-modality imaging systems in pre-clinical research studies, and the increased acceptance of pre-clinical imaging in drug discovery and development, the report found.
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
This greater demand was offset by declining NIH budgets for medical science research studies, and high implementation cost of sophisticated pre-clinical imaging systems, the report also advised.
As of 2014, North America holds the largest share of the global pre-clinical imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2 percent from 2014 to 2019.
